In another study, using the HepG2 cell line and HCC-containing tissues, Lu et al. utilized bioinformatics to identify let-7b and miR-17 microRNAs as targets of CD46 signaling (68). The gene discussed is CD46; the disease is hepatocellular carcinoma.